The deduction of VAT paid on the importation of “modified genes” not owned by the importer destined for clinical trials conducted by third parties is allowed which, if concluded positively, will allow the importer to market the related drugs obtained.
Source PwC
Latest Posts in "Italy"
- Local Authority Reimbursements for Employee Electoral Mandate Leave Not Subject to VAT
- VAT Refund Denied in Fraud Context After Contract Reclassification
- Italy’s Supreme Court Redefines Territoriality Through Substance
- Upcoming Consolidated VAT Code to streamline regulations
- Italian Tax Agency Communication on VAT Declaration Discrepancies for 2023 Tax Period
